Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Eligard (Leuprolide Acetate) Injectable Suspension
Company: Atrix Laboratories
Application No.:  021731
Approval Date: 12/14/2004


Date created: September 272006

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.